(Q24604349)

2

object named as

Michael Hertl

0 references

author name string

Benjamin S Daniel

1

0 references

Victoria P Werth

3

0 references

Dédée F Murrell

5

0 references

language of work or name

English

0 references

publication date

2012

1 reference

Interventions for pemphigus vulgaris and pemphigus foliaceus

published in

Clinics in Dermatology

0 references

volume

30

0 references

issue

1

0 references

page(s)

108-13

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928011

Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928011

Reliability and convergent validity of two outcome instruments for pemphigus

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928011

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928011

Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928011

A new method for measuring progression in patients with ocular cicatricial pemphigoid

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928011

A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatoses

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928011

Clinical significance of autoantibodies in pemphigus.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928011

Correlation of immunological profile with phenotype and disease outcome in pemphigus.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928011

Pemphigus: active or inactive?

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928011

Clinical and immunological follow-up of pemphigus patients on adjuvant treatment with immunoadsorption or rituximab

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928011

The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928011

Treatment of pemphigus: the need for more evidence

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928011

Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928011

History of the establishment and revision of diagnostic criteria, severity index and therapeutic guidelines for pemphigus in Japan.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928011

A comparison of oral and topical corticosteroids in patients with bullous pemphigoid

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928011

The correlation of disease activity and antibody titers in pemphigus.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928011

28 November 2018

Cicatricial pemphigoid

1 reference

12 December 2020

A new grading system for oral pemphigus

1 reference

12 December 2020

The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels

1 reference

12 December 2020

Ocular cicatricial pemphigoid

1 reference

12 December 2020

Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies)

1 reference

12 December 2020

Patterns of remission in pemphigus vulgaris

1 reference

12 December 2020

Pemphigus Area and Activity Score (PAAS)--a novel clinical scoring method for monitoring of pemphigus vulgaris patients

1 reference

12 December 2020

Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins

1 reference

12 December 2020

Improved detection of disease progression in ocular cicatricial pemphigoid

1 reference

12 December 2020